Researchers have said that the pre-clinical testing of The University of Queensland’s COVID-19 vaccine has produced safe results. It has also been proven that the vaccine can be mass produced. Results from animal testing show that the vaccine produces a good immune response and can be manufactured in large quantities once it has been finanlised.
In April, we released an article about the University of Queensland when the University were working on developing the vaccine.
In just a few short months since SSKB found out about the work being done by the University of Queensland’s efforts to develop a vaccine, they have progressed to human trials and are now presenting their initial findings.
The UQ team is expecting to complete phase one if their human trials by the end of the year. After this CSL will take over the final stages of trials. If the vaccine passes these trials, it could be ready to use in the second half of 2021.
Click here to read more updates about the vaccine from UQ.
SSKB are proud supporters of the UQ research
At SSKB, we are proud supporters of the UQ research. We have been able to support the University of Queensland appeal by donating $5,000 towards the research of the vaccine. The project has the potential to change lives in Australia and around the world.
While we understand that many are facing hardship during these times, we also recognise that many of our clients would like to personally support the research at UQ.
Donations could help reduce the timeline for an effective vaccine for COVID-19 by six months and advance vaccine research at UQ to prepare for future outbreaks.
The University is calling on the community to support the COVID-19 vaccine research with a donation of any amount.
To give to the Coronavirus (COVID-19) Research fund, please click here
To stay up to date with the latest COVID-19 updates and how they may affect your Bodies Corporate/owners Corporation click here.